Ocular Therapeutix, Inc. remote work and careers
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes. AXPAXLI™ (also known as OTX-TKI), an investigational axitinib hydrogel administered by intravitreal injection, is Ocular’s leading investigational candidate for retinal disease, based on its proprietary ELUTYX™ technology.…
About Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes. AXPAXLI™ (also known as OTX-TKI), an investigational axitinib hydrogel administered by intravitreal injection, is Ocular’s leading investigational candidate for retinal disease, based on its proprietary ELUTYX™ technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD) and has potential applications across other retinal diseases such as non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME).
Mission and direction
Ocular Therapeutix is a biopharmaceutical company dedicated to developing and commercializing innovative ophthalmic therapies using its proprietary bioresorbable hydrogel-based ELUTYX™ technology. The company focuses on reducing the complexity and burden of eye disease treatment by advancing drug-delivery solutions and a pipeline of products for retinal and other ocular diseases.
Company values
- Innovation
- Collaboration
- Integrity
- Patient focus
- Excellence
- Agility